{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:47:17Z","timestamp":1787028437952,"version":"build-2736575974"},"reference-count":110,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Transthyretin (TTR), previously named prealbumin is a plasma protein secreted mainly by the liver and choroid plexus (CP) that is a carrier for thyroid hormones (THs) and retinol (vitamin A). The structure of TTR, with four monomers rich in \u03b2-chains in a globular tetrameric protein, accounts for the predisposition of the protein to aggregate in fibrils, leading to a rare and severe disease, namely transthyretin amyloidosis (ATTR). Much effort has been made and still is required to find new therapeutic compounds that can stabilize TTR (\u201ckinetic stabilization\u201d) and prevent the amyloid genetic process. Moreover, TTR is an interesting therapeutic target for neurodegenerative diseases due to its recognized neuroprotective properties in the cognitive impairment context and interestingly in Alzheimer\u2019s disease (AD). Much evidence has been collected regarding the neuroprotective effects in AD, including through in vitro and in vivo studies as well as a wide range of clinical series. Despite this supported hypothesis of neuroprotection for TTR, the mechanisms are still not completely clear. The aim of this review is to highlight the most relevant findings on the neuroprotective role of TTR, and to summarize the recent progress on the development of TTR tetramer stabilizers.<\/jats:p>","DOI":"10.3390\/ijms21228672","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T11:02:12Z","timestamp":1605610932000},"page":"8672","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer\u2019s Disease?"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0277-1648","authenticated-orcid":false,"given":"Federica","family":"Saponaro","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Pisa, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6776-2451","authenticated-orcid":false,"given":"Jin Hae","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of New Biology, Daegu Gyeongbuk Institute of Science &amp; Technology (DGIST), Daegu 42988, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6703-5820","authenticated-orcid":false,"given":"Grazia","family":"Chiellini","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pisa, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11793","DOI":"10.1016\/S0021-9258(17)39100-7","article-title":"Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat","volume":"260","author":"Soprano","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1515\/bmc-2013-0038","article-title":"Transthyretin: A multifaceted protein","volume":"5","author":"Vieira","year":"2014","journal-title":"Biomol. Concepts"},{"key":"ref_3","unstructured":"INGBAR, S.H. (1958). Pre-albumin: A thyroxinebinding protein of human plasma. Endocrinology."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1016\/S0021-9258(18)93118-2","article-title":"The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex","volume":"244","author":"Raz","year":"1969","journal-title":"J. Biol. Chem."},{"key":"ref_5","unstructured":"Nomenclature Committee of the International Union of Biochemistry (NC-IUB) (1980). Enzyme Nomenclature. Recommendations 1978. Supplement 1: Corrections and additions. Eur. J. Biochem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0305-0491(96)00212-X","article-title":"The evolution of gene expression, structure and function of transthyretin","volume":"116","author":"Schreiber","year":"1997","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/gcen.2000.7520","article-title":"Evolution of the thyroid hormone-binding protein, transthyretin","volume":"119","author":"Power","year":"2000","journal-title":"Gen. Comp. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Eneqvist, T., Lundberg, E., Nilsson, L., Abagyan, R., and Sauer-Eriksson, A.E. (2003). The transthyretin-related protein family. Eur. J. Biochem.","DOI":"10.1046\/j.1432-1033.2003.03408.x"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/PL00000791","article-title":"Transthyretin: A review from a structural perspective","volume":"58","author":"Hamilton","year":"2001","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wojtczak, A. (1997). Crystal structure of rat transthyretin at 2.5 \u00c5 resolution: First report on a unique tetrameric structure. Acta Biochim. Pol.","DOI":"10.18388\/abp.1997_4400"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.2174\/092986712800269335","article-title":"Nearly 200 X-Ray Crystal Structures of Transthyretin: What Do They Tell Us About This Protein and the Design of Drugs for TTR Amyloidoses?","volume":"19","author":"Palaninathan","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.20821","article-title":"The molecular biology and clinical features of amyloid neuropathy","volume":"36","author":"Benson","year":"2007","journal-title":"Muscle Nerve"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/jnnp-2014-308724","article-title":"Transthyretin (ATTR) amyloidosis: Clinical spectrum, molecular pathogenesis and disease-modifying treatments","volume":"86","author":"Sekijima","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_14","unstructured":"Adam, M.P., Ardinger, H.H., and Pagon, R.A. (2001). Hereditary Transthyretin Amyloidosis Summary Genetic counseling GeneReview Scope Suggestive Findings. GeneReviews NCBI Bookshelf, University of Washington."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Cornwell, G.G., Murdoch, W.L., Kyle, R.A., Westermark, P., and Pitk\u00e4nen, P. (1983). Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am. J. Med.","DOI":"10.1016\/0002-9343(83)90443-6"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Westermark, P., Sletten, K., Johansson, B., and Cornwell, G.G. (1990). Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl. Acad. Sci. USA.","DOI":"10.1073\/pnas.87.7.2843"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Holmgren, G., Steen, L., Suhr, O., Ericzon, B.G., Groth, C.G., Andersen, O., Wallin, B.G., Seymour, A., Richardson, S., and Hawkins, P.N. (1993). Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet.","DOI":"10.1016\/0140-6736(93)93127-M"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/jcpt.12145","article-title":"Recent progress in the understanding and treatment of transthyretin amyloidosis","volume":"39","author":"Sekijima","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Berk, J.L., Suhr, O.B., Obici, L., Sekijima, Y., Zeldenrust, S.R., Yamashita, T., Heneghan, M.A., Gorevic, P.D., Litchy, W.J., and Wiesman, J.F. (2013). Repurposing diflunisal for familial amyloid polyneuropathy: A randomized clinical trial. JAMA-J. Am. Med. Assoc.","DOI":"10.1001\/jama.2013.283815"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Coelho, T., Maia, L.F., Da Silva, A.M., Cruz, M.W., Plant\u00e9-Bordeneuve, V., Lozeron, P., Suhr, O.B., Campistol, J.M., Concei\u00e7\u00e3o, I.M., and Schmidt, H.H.J. (2012). Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial. Neurology.","DOI":"10.1212\/WNL.0b013e3182661eb1"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Silva, C.S., Eira, J., Ribeiro, C.A., Oliveira, \u00c2., Sousa, M.M., Cardoso, I., and Liz, M.A. (2017). Transthyretin neuroprotection in Alzheimer\u2019s disease is dependent on proteolysis. Neurobiol. Aging.","DOI":"10.1016\/j.neurobiolaging.2017.07.002"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Alemi, M., Silva, S.C., Santana, I., and Cardoso, I. (2017). Transthyretin stability is critical in assisting beta amyloid clearance\u2013Relevance of transthyretin stabilization in Alzheimer\u2019s disease. CNS Neurosci. Ther.","DOI":"10.1111\/cns.12707"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Schwarzman, A.L., Gregori, L., Vitek, M.P., Lyubski, S., Strittmatter, W.J., Enghilde, J.J., Bhasin, R., Silverman, J., Weisgraber, K.H., and Coyle, P.K. (1994). Transthyretin sequesters amyloid \u03b2 protein and prevents amyloid formation. Proc. Natl. Acad. Sci. USA.","DOI":"10.1073\/pnas.91.18.8368"},{"key":"ref_24","unstructured":"Schwarzman, A.L., and Goldgaber, D. (1996). Interaction of transthyretin with amyloid \u03b2-protein: Binding and inhibition of amyloid formation. CIBA Found. Symp."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Buxbaum, J.N., Ye, Z., Reixach, N., Friske, L., Levy, C., Das, P., Golde, T., Masliah, E., Roberts, A.R., and Bartfai, T. (2008). Transthyretin protects Alzheimer\u2019s mice from the behavioral and biochemical effects of A\u03b2 toxicity. Proc. Natl. Acad. Sci. USA.","DOI":"10.1073\/pnas.0712197105"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Oliveira, S.M., Ribeiro, C.A., Cardoso, I., and Saraiva, M.J. (2011). Gender-dependent transthyretin modulation of brain amyloid-\u03b2 Levels: Evidence from a mouse model of alzheimer\u2019s disease. J. Alzheimers Dis.","DOI":"10.3233\/JAD-2011-110488"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Marrero, I., Gim\u00e9nez-Llort, L., Johanson, C.E., Carmona-Calero, E.M., Casta\u00f1eyra-Ruiz, L., Brito-Armas, J.M., Casta\u00f1eyra-Perdomo, A., and Castro-Fuentes, R. (2015). Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of alzheimer\u2019s disease. Front. Cell. Neurosci.","DOI":"10.3389\/fncel.2015.00017"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Alemi, M., Gaiteiro, C., Ribeiro, C.A., Santos, L.M., Gomes, J.R., Oliveira, S.M., Couraud, P.O., Weksler, B., Romero, I., and Saraiva, M.J. (2016). Transthyretin participates in beta-amyloid transport from the brain to the liver-involvement of the low-density lipoprotein receptor-related protein 1?. Sci. Rep.","DOI":"10.1038\/srep20164"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Santos, S.D., Lambertsen, K.L., Clausen, B.H., Akinc, A., Alvarez, R., Finsen, B., and Saraiva, M.J. (2010). CSF transthyretin neuroprotection in a mouse model of brain ischemia. J. Neurochem.","DOI":"10.1111\/j.1471-4159.2010.07047.x"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Fleming, C.E., Saraiva, M.J., and Sousa, M.M. (2007). Transthyretin enhances nerve regeneration. J. Neurochem.","DOI":"10.1111\/j.1471-4159.2007.04828.x"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Sousa, J.C., Marques, F., Dias-Ferreira, E., Cerqueira, J.J., Sousa, N., and Palha, J.A. (2007). Transthyretin influences spatial reference memory. Neurobiol. Learn. Mem.","DOI":"10.1016\/j.nlm.2007.07.006"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Li, X., Masliah, E., Reixach, N., and Buxbaum, J.N. (2011). Neuronal production of transthyretin in human and murine alzheimer\u2019s disease: Is it protective?. J. Neurosci.","DOI":"10.1523\/JNEUROSCI.2417-11.2011"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Stabilini, R., Vergani, C., Agostoni, A., and Agostoni, R.P.V. (1968). Influence of age and sex on prealbumin levels. Clin. Chim. Acta.","DOI":"10.1016\/0009-8981(68)90173-3"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Vahlquist, A., Rask, L., Peterson, P.A., and Berg, T. (1975). The concentrations of retinol-binding protein, prealbumin, and transferrin in the sera of newly delivered mothers and children of various ages. Scand. J. Clin. Lab. Invest.","DOI":"10.1080\/00365517509095782"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Schreiber, G., Aldred, A.R., Jaworowski, A., Nilsson, C., Achen, M.G., and Segal, M.B. (1990). Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus. Am. J. Physiol.-Regul. Integr. Comp. Physiol.","DOI":"10.1152\/ajpregu.1990.258.2.R338"},{"key":"ref_36","first-page":"23","article-title":"Expression of transthyretin and retinol binding protein mRNAs and secretion of transthyretin by cultured monkey retinal pigment epithelium","volume":"10","author":"Pfeffer","year":"2004","journal-title":"Mol. Vis."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kato, M., Kato, K., Blaner, W.S., Chertow, B.S., and Goodman, D.S. (1985). Plasma and cellular retinoid-binding proteins and transthyretin (prealbumin) are all localized in the islets of Langerhans in the rat. Proc. Natl. Acad. Sci. USA.","DOI":"10.1073\/pnas.82.8.2488"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Jacobsson, B., Collins, V.P., Grimelius, L., Pettersson, T., Sandstedt, B., and Carlstrom, A. (1989). Transthyretin immunoreactivity in human and porcine liver, choroid plexus, and pancreatic islets. J. Histochem. Cytochem.","DOI":"10.1177\/37.1.2642294"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Hagen, G.A., and Solberg, L.A. (1974). Brain and cerebrospinal fluid permeability to intravenous thyroid hormones. Endocrinology.","DOI":"10.1210\/endo-95-5-1398"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Palha, J.A. (2002). Transthyretin as a thyroid hormone carrier: Function revisited. Clin. Chem. Lab. Med.","DOI":"10.1515\/CCLM.2002.223"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Blake, C.C.F., Geisow, M.J., Swan, I.D.A., Rerat, C., and Rerat, B. (1974). Structure of human plasma prealbumin at 2.5 A resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding. J. Mol. Biol.","DOI":"10.1016\/0022-2836(74)90291-5"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Tomar, D., Khan, T., Singh, R.R., Mishra, S., Gupta, S., Surolia, A., and Salunke, D.M. (2012). Crystallographic Study of Novel Transthyretin Ligands Exhibiting Negative-Cooperativity between Two Thyroxine Binding Sites. PLoS ONE.","DOI":"10.2210\/pdb4ank\/pdb"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kanai, M., Raz, A., and Goodman, D.S. (1968). Retinol-binding protein: The transport protein for vitamin A in human plasma. J. Clin. Invest.","DOI":"10.1172\/JCI105889"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJM198404193101605","article-title":"Vitamin A and Retinoids in Health and Disease","volume":"310","author":"Epstein","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Noy, N., Slosberg, E., and Scarlatal, S. (1992). Interactions of Retinol with Binding Proteins: Studies with Retinol-Binding Protein and with Transthyretin. Biochemistry.","DOI":"10.1021\/bi00160a023"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Monaco, H.L., Rizzi, M., and Coda, A. (1995). Structure of a complex of two plasma proteins: Transthyretin and retinol-binding protein. Science.","DOI":"10.1126\/science.7754382"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Van Bennekum, A.M., Wei, S., Gamble, M.V., Vogel, S., Piantedosi, R., Gottesman, M., Episkopoui, V., and Blaner, W.S. (2001). Biochemical basis for depressed serum retinol levels in transthyretin-deficient mice. J. Biol. Chem.","DOI":"10.1074\/jbc.M008091200"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Liz, M.A., Faro, C.J., Saraiva, M.J., and Sousa, M.M. (2004). Transthyretin, a new cryptic protease. J. Biol. Chem.","DOI":"10.1074\/jbc.M402212200"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Liz, M.A., Gomes, C.M., Saraiva, M.J., and Sousa, M.M. (2007). ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity. J. Lipid Res.","DOI":"10.1194\/jlr.M700158-JLR200"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0022-2275(20)32074-5","article-title":"Transthyretin in high density lipoproteins: Association with apolipoprotein A-I","volume":"41","author":"Sousa","year":"2000","journal-title":"J. Lipid Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Liz, M.A., Fleming, C.E., Nunes, A.F., Almeida, M.R., Mar, F.M., Choe, Y., Craik, C.S., Powers, J.C., Bogyo, M., and Sousa, M.M. (2009). Substrate specificity of transthyretin: Identification of natural substrates in the nervous system. Biochem. J.","DOI":"10.1042\/BJ20082090"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Costa, R., Ferreira-da-Silva, F., Saraiva, M.J., and Cardoso, I. (2008). Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: A mechanism sensitive to the kunitz protease inhibitor. PLoS ONE.","DOI":"10.1371\/journal.pone.0002899"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1586\/eem.12.2","article-title":"Transthyretin: Roles in the nervous system beyond thyroxine and retinol transport","volume":"7","author":"Oliveira","year":"2012","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Brouillette, J., and Quirion, R. (2008). Transthyretin: A key gene involved in the maintenance of memory capacities during aging. Neurobiol. Aging.","DOI":"10.1016\/j.neurobiolaging.2007.04.007"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Carlos Sousa, J., Grandela, C., Fern\u00e1ndez-Ruiz, J., De Miguel, R., De Sousa, L., Magalh\u00e3es, A.I., Jo\u00e3o Saraiva, M., Sousa, N., and Palha, J.A. (2004). Transthyretin is involved in depression-like behaviour and exploratory activity. J. Neurochem.","DOI":"10.1046\/j.1471-4159.2003.02309.x"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Fleming, C.E., Mar, F.M., Franquinho, F., Saraiva, M.J., and Sousa, M.M. (2009). Transthyretin internalization by sensory neurons is megalin mediated and necessary for its neuritogenic activity. J. Neurosci.","DOI":"10.1523\/JNEUROSCI.6012-08.2009"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Chen, R., Vendrell, I., Chen, C.P., Cash, D., O\u2019Toole, K.G., Williams, S.A., Jones, C., Preston, J.E., and Wheeler, J.X. (2011). Proteomic analysis of rat plasma following transient focal cerebral ischemia. Biomark. Med.","DOI":"10.2217\/bmm.11.89"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Suzuyama, K., Shiraishi, T., Oishi, T., Ueda, S., Okamoto, H., Furuta, M., Mineta, T., and Tabuchi, K. (2004). Combined proteomic approach with SELDI-TOF-MS and peptide mass fingerprinting identified the rapid increase of monomeric transthyretin in rat cerebrospinal fluid after transient focal cerebral ischemia. Mol. Brain Res.","DOI":"10.1016\/j.molbrainres.2004.06.021"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Liverman, C.S., Cui, L., Yong, C., Choudhuri, R., Klein, R.M., Welch, K.M.A., and Berman, N.E.J. (2004). Response of the brain to oligemia: Gene expression, c-Fos, and Nrf2 localization. Mol. Brain Res.","DOI":"10.1016\/S0169-328X(04)00163-9"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A century of Alzheimer\u2019s disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Funato, H., Enya, M., Yoshimura, M., Morishima-Kawashima, M., and Ihara, Y. (1999). Presence of sodium dodecyl sulfate-stable amyloid \u03b2-protein dimers in the hippocampus CA1 not exhibiting neurofibrillary tangle formation. Am. J. Pathol.","DOI":"10.1016\/S0002-9440(10)65094-8"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Bateman, R.J., Xiong, C., Benzinger, T.L.S., Fagan, A.M., Goate, A., Fox, N.C., Marcus, D.S., Cairns, N.J., Xie, X., and Blazey, T.M. (2012). Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N. Engl. J. Med.","DOI":"10.1056\/NEJMoa1202753"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nm1113","article-title":"Neurodegenerative diseases: A decade of discoveries paves the way for therapeutic breakthroughs","volume":"10","author":"Forman","year":"2004","journal-title":"Nat. Med."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Elovaara, I., Maury, C.P.J., and Palo, J. (1986). Serum amysoid A protein, albumin and prealbumin in Alzheimer\u2019s disease and in demented patients with Down\u2019s syndrome. Acta Neurol. Scand.","DOI":"10.1111\/j.1600-0404.1986.tb07863.x"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Serot, J.M., Christmann, D., Dubost, T., and Couturier, M. (1997). Cerebrospinal fluid transthyretin: Aging and late onset Alzheimer\u2019s disease. J. Neurol. Neurosurg. Psychiatry.","DOI":"10.1136\/jnnp.63.4.506"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Li, X., Zhang, X., Ladiwala, A.R.A., Du, D., Yadav, J.K., Tessier, P.M., Wright, P.E., Kelly, J.W., and Buxbaum, J.N. (2013). Mechanisms of transthyretin inhibition of \u03b2-amyloid aggregation in vitro. J. Neurosci.","DOI":"10.1523\/JNEUROSCI.2561-13.2013"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Liu, L., and Murphy, R.M. (2006). Kinetics of inhibition of \u03b2-amyloid aggregation by transthyretin. Biochemistry.","DOI":"10.1021\/bi0618520"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Gloeckner, S.F., Meyne, F., Wagner, F., Heinemann, U., Krasnianski, A., Meissner, B., and Zerr, I. (2008). Quantitative analysis of transthyretin, tau and amyloid-\u03b2 in patients with dementia. J. Alzheimers Dis.","DOI":"10.3233\/JAD-2008-14102"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Han, S.H., Jung, E.S., Sohn, J.H., Hong, H.J., Hong, H.S., Kim, J.W., Na, D.L., Kim, M., Kim, H., and Ha, H.J. (2011). Human serum transthyretin levels correlate inversely with Alzheimer\u2019s disease. J. Alzheimers Dis.","DOI":"10.3233\/JAD-2011-102145"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Ribeiro, C.A., Saraiva, M.J., and Cardoso, I. (2012). Stability of the Transthyretin Molecule as a Key Factor in the Interaction with A-Beta Peptide-Relevance in Alzheimer\u2019s Disease. PLoS ONE.","DOI":"10.1371\/journal.pone.0045368"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Velayudhan, L., Killick, R., Hye, A., Kinsey, A., G\u00fcntert, A., Lynham, S., Ward, M., Leung, R., Lourdusamy, A., and To, A.W.M. (2012). Plasma transthyretin as a candidate marker for Alzheimer\u2019s disease. J. Alzheimers Dis.","DOI":"10.3233\/JAD-2011-110611"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-55318-0","article-title":"Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia","volume":"9","author":"Tien","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Kim, H.S., Choi, Y., Shin, K.Y., Joo, Y., Lee, Y.K., Jung, S.Y., Suh, Y.H., and Kim, J.H. (2007). Swedish amyloid precursor protein mutation increases phosphorylation of eIF2\u03b1 in vitro and in vivo. J. Neurosci. Res.","DOI":"10.1002\/jnr.21267"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Tagoe, C.E., Reixach, N., Friske, L., Mustra, D., French, D., Gallo, G., and Buxbaum, J.N. (2007). In vivo stabilization of mutant human transthyretin in transgenic mice. Amyloid.","DOI":"10.1080\/13506120701464396"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Link, C.D. (1995). Expression of human \u03b2-amyloid peptide in transgenic Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA.","DOI":"10.1073\/pnas.92.20.9368"},{"key":"ref_78","unstructured":"Se, H.C., Leight, S.N., Lee, V.M.Y., Li, T., Wong, P.C., Johnson, J.A., Saraiva, M.J., and Sisodia, S.S. (2007). Accelerated A\u03b2 deposition in APPswe\/PS1\u0394E9 mice with hemizygous deletions of TTR (transthyretin). J. Neurosci."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Ghadami, S.A., Chia, S., Ruggeri, F.S., Meisl, G., Bemporad, F., Habchi, J., Cascella, R., Dobson, C.M., Vendruscolo, M., and Knowles, T.P.J. (2020). Transthyretin Inhibits Primary and Secondary Nucleations of Amyloid-\u03b2 Peptide Aggregation and Reduces the Toxicity of Its Oligomers. Biomacromolecules.","DOI":"10.1021\/acs.biomac.9b01475"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"A. Ribeiro, C., Santana, I., Oliveira, C., Baldeiras, I., Moreira, J., Joao Saraiva, M., and Cardoso, I. (2012). Transthyretin Decrease in Plasma of MCI and AD Patients: Investigation of Mechanisms for Disease Modulation. Curr. Alzheimer Res.","DOI":"10.2174\/156720512803251057"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Du, J., and Murphy, R.M. (2010). Characterization of the interaction of \u03b2-Amyloid with Transthyretin monomers and tetramers. Biochemistry.","DOI":"10.1021\/bi101280t"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Costa, R., Gon\u00e7alves, A., Saraiva, M.J., and Cardoso, I. (2008). Transthyretin binding to A-Beta peptide-Impact on A-Beta fibrillogenesis and toxicity. FEBS Lett.","DOI":"10.1016\/j.febslet.2008.02.034"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"McCutchen, S.L., Colon, W., and Kelly, J.W. (1993). Transthyretin Mutation Leu-55-Pro Significantly Alters Tetramer Stability and Increases Amyloidogenicity. Biochemistry.","DOI":"10.1021\/bi00096a024"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Xiang, Q., Bi, R., Xu, M., Zhang, D.F., Tan, L., Zhang, C., Fang, Y., and Yao, Y.G. (2017). Rare Genetic Variants of the Transthyretin Gene Are Associated with Alzheimer\u2019s Disease in Han Chinese. Mol. Neurobiol.","DOI":"10.1007\/s12035-016-0065-2"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Sassi, C., Ridge, P.G., Nalls, M.A., Gibbs, R., Ding, J., Lupton, M.K., Troakes, C., Lunnon, K., Al-Sarraj, S., and Brown, K.S. (2016). Influence of coding variability in APP-A\u03b2 metabolism genes in sporadic Alzheimer\u2019s disease. PLoS ONE.","DOI":"10.1371\/journal.pone.0150079"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Hurshman, A.R., White, J.T., Powers, E.T., and Kelly, J.W. (2004). Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry.","DOI":"10.1021\/bi049621l"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Quintela, T., Gon\u00e7alves, I., Baltazar, G., Alves, C.H., Saraiva, M.J., and Santos, C.R.A. (2009). 17\u03b2-estradiol induces transthyretin expression in murine choroid plexus via an oestrogen receptor dependent pathway. Cell. Mol. Neurobiol.","DOI":"10.1007\/s10571-008-9339-1"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1196\/annals.1386.008","article-title":"Age-related inflammatory diseases: Role of genetics and gender in the pathophysiology of Alzheimer\u2019s disease","volume":"10889","author":"Candore","year":"2006","journal-title":"Proc. Ann. N. Y. Acad. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Munro, S.L., Lim, C.F., Hall, J.G., Barlow, J.W., Craik, D.J., Topliss, D.J., and Stockigt, J.R. (1989). Drug competition for thyroxine binding to transthyretin (prealbumin): Comparison with effects on thyroxine-binding globulin. J. Clin. Endocrinol. Metab.","DOI":"10.1210\/jcem-68-6-1141"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Adamski-Werner, S.L., Palaninathan, S.K., Sacchettini, J.C., and Kelly, J.W. (2004). Diflunisal Analogues Stabilize the Native State of Transthyretin. Potent Inhibition of Amyloidogenesis. J. Med. Chem.","DOI":"10.1021\/jm030347n"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Miller, S.R., Sekijima, Y., and Kelly, J.W. (2004). Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants. Lab. Investig.","DOI":"10.1038\/labinvest.3700059"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Ribeiro, C.A., Oliveira, S.M., Guido, L.F., Magalh\u00e3es, A., Valencia, G., Arsequell, G., Saraiva, M.J., and Cardoso, I. (2014). Transthyretin stabilization by iododiflunisal promotes amyloid-\u03b2 peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer\u2019s disease mouse model. J. Alzheimers Dis.","DOI":"10.3233\/JAD-131355"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Rios, X., G\u00f3mez-Vallejo, V., Mart\u00edn, A., Coss\u00edo, U., Morcillo, M.\u00c1., Alemi, M., Cardoso, I., Quintana, J., Jim\u00e9nez-Barbero, J., and Cotrina, E.Y. (2019). Radiochemical examination of transthyretin (TTR) brain penetration assisted by iododiflunisal, a TTR tetramer stabilizer and a new candidate drug for AD. Sci. Rep.","DOI":"10.1038\/s41598-019-50071-w"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Maurer, M.S., Schwartz, J.H., Gundapaneni, B., Elliott, P.M., Merlini, G., Waddington-Cruz, M., Kristen, A.V., Grogan, M., Witteles, R., and Damy, T. (2018). Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N. Engl. J. Med.","DOI":"10.1056\/NEJMoa1805689"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Benson, M.D., Waddington-Cruz, M., Berk, J.L., Polydefkis, M., Dyck, P.J., Wang, A.K., Plant\u00e9-Bordeneuve, V., Barroso, F.A., Merlini, G., and Obici, L. (2018). Inotersen treatment for patients with Hereditary transthyretin amyloidosis. N. Engl. J. Med.","DOI":"10.1056\/NEJMoa1716793"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Coelho, T., Adams, D., Silva, A., Lozeron, P., Hawkins, P.N., Mant, T., Perez, J., Chiesa, J., Warrington, S., and Tranter, E. (2013). Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N. Engl. J. Med.","DOI":"10.1056\/NEJMoa1208760"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Butler, J.S., Chan, A., Costelha, S., Fishman, S., Willoughby, J.L.S., Borland, T.D., Milstein, S., Foster, D.J., Gon\u00e7alves, P., and Chen, Q. (2016). Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis. Amyloid.","DOI":"10.3109\/13506129.2016.1160882"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Zhang, X., Goel, V., and Robbie, G.J. (2019). Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin-Mediated Amyloidosis. J. Clin. Pharmacol.","DOI":"10.1002\/jcph.1553"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Jayaraman, M., Ansell, S.M., Mui, B.L., Tam, Y.K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., and Narayanannair, J.K. (2012). Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew. Chemie-Int. Ed.","DOI":"10.1002\/anie.201203263"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Garber, K. (2016). Alnylam terminates revusiran program, stock plunges. Nat. Biotechnol.","DOI":"10.1038\/nbt1216-1213"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Adams, D., Gonzalez-Duarte, A., O\u2019Riordan, W.D., Yang, C.C., Ueda, M., Kristen, A.V., Tournev, I., Schmidt, H.H., Coelho, T., and Berk, J.L. (2018). Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N. Engl. J. Med.","DOI":"10.1056\/NEJMoa1716153"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Wood, H. (2018). FDA approves patisiran to treat hereditary transthyretin amyloidosis. Nat. Rev. Neurol.","DOI":"10.1038\/s41582-018-0065-0"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Kristen, A.V., Ajroud-Driss, S., Concei\u00e7\u00e3o, I., Gorevic, P., Kyriakides, T., and Obici, L. (2019). Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis. Neurodegener. Dis. Manag.","DOI":"10.2217\/nmt-2018-0033"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/14756366.2020.1760262","article-title":"Natural compounds as inhibitors of transthyretin amyloidosis and neuroprotective agents: Analysis of structural data for future drug design","volume":"335","author":"Ciccone","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Marambaud, P., Zhao, H., and Davies, P. (2005). Resveratrol promotes clearance of Alzheimer\u2019s disease amyloid-\u03b2 peptides. J. Biol. Chem.","DOI":"10.1074\/jbc.M508246200"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mnfr.201400290","article-title":"Natural polyphenols binding to amyloid: A broad class of compounds to treat different human amyloid diseases","volume":"59","author":"Ngoungoure","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Ortore, G., Orlandini, E., Braca, A., Ciccone, L., Rossello, A., Martinelli, A., and Nencetti, S. (2016). Targeting Different Transthyretin Binding Sites with Unusual Natural Compounds. ChemMedChem.","DOI":"10.1002\/cmdc.201600092"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Kristen, A.V., Lehrke, S., Buss, S., Mereles, D., Steen, H., Ehlermann, P., Hardt, S., Giannitsis, E., Schreiner, R., and Haberkorn, U. (2012). Green tea halts progression of cardiac transthyretin amyloidosis: An observational report. Clin. Res. Cardiol.","DOI":"10.1007\/s00392-012-0463-z"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Aus dem Siepen, F., Bauer, R., Aurich, M., Buss, S.J., Steen, H., Altland, K., Katus, H.A., and Kristen, A.V. (2015). Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: An observational study. Drug Des. Devel. Ther.","DOI":"10.2147\/DDDT.S96893"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Ferreira, N., Gon\u00e7alves, N.P., Saraiva, M.J., and Almeida, M.R. (2016). Curcumin: A multi-Target disease-modifying agent for late-stage transthyretin amyloidosis. Sci. Rep.","DOI":"10.1038\/srep26623"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/22\/8672\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:34:39Z","timestamp":1760178879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/22\/8672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":110,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["ijms21228672"],"URL":"https:\/\/doi.org\/10.3390\/ijms21228672","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]}}}